SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. ETFs Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Hong Kong S.E.
Equities
2196
CNE100001M79
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.28 HKD | -2.78% |
|
-0.30% | -21.88% |
| 01/07 | Shanghai Fosun Pharmaceutical Co., Ltd. Announces Board and Board Committee Changes | CI |
| 28/06 | Shanghai Fosun Pharmaceutical Gets Registration Application Approval for Chest Pain Drug | MT |
ETFs positioned on Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.37% | 4 M€ | -27.92% | ||
| 0.63% | 1 M€ | -25.54% | - | |
| 0.21% | 2 M€ | -2.90% | - | |
| 0.18% | 2 M€ | -14.14% | ||
| 0.16% | 4 M€ | -11.56% | ||
| 0.03% | 35 M€ | -5.85% | - | |
| 0.02% | 451 M€ | +9.23% | - | |
| 0.02% | 2,838 M€ | +12.46% | - | |
| 0.02% | 152 M€ | +9.95% | - | |
| 0.02% | 4 M€ | -4.41% | - | |
| 0.01% | 35 M€ | +6.70% | - | |
| 0.01% | 114 M€ | +7.37% | - | |
| 0.00% | 36 M€ | +10.72% | - | |
| 0.00% | 32 M€ | +4.91% | - | |
| 0.00% | 40 M€ | +7.18% | - | |
| 0.00% | 324 M€ | +8.69% | - | |
| 0.00% | 7 M€ | +0.11% | - | |
| 0.00% | 17 M€ | +3.51% | - | |
| 0.00% | 15 M€ | +23.70% | ||
| 0.00% | 7 M€ | +5.72% | - | |
| 0.00% | 8 M€ | +0.48% | - |
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a pharmaceutical group organized around 4 areas of activities:
- research, development and manufacturing of medicines (72.1% of net sales): for the treatment of cardiovascular diseases, digestive tract, metabolism, central nervous system and blood system disorders, and infectious diseases;
- sale of medical equipments and diagnosis products (17.3%);
- medical and hospital services (10.5%);
- other (0.1%).
China accounts for 72.9% of net sales.
Sector
Pharmaceuticals
Calendar
28/08/2024
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
22.32
CNY
Average target price
28.61
CNY
Spread / Average Target
+28.17%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +56.89% | 82TCr | |
| +40.51% | 63TCr | |
| -6.55% | 35TCr | |
| +15.99% | 32TCr | |
| +7.92% | 30TCr | |
| +13.85% | 24TCr | |
| +13.56% | 22TCr | |
| -0.57% | 22TCr | |
| +7.94% | 17TCr |
- Stock Market
- Equities
- 600196 Stock
- 2196 Stock
- ETFs Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
